- Home
- TCMD vs PROK Comparison
TCMD vs PROK Comparison
Compare TCMD & PROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCMD
- PROK
- Stock Information
- Founded
- TCMD 1995
- PROK 2015
- Country
- TCMD United States
- PROK United States
- Employees
- TCMD N/A
- PROK N/A
- Industry
- TCMD Medical/Dental Instruments
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TCMD Health Care
- PROK Health Care
- Exchange
- TCMD Nasdaq
- PROK Nasdaq
- Market Cap
- TCMD 300.1M
- PROK 334.8M
- IPO Year
- TCMD 2016
- PROK N/A
- Fundamental
- Price
- TCMD $14.90
- PROK $3.37
- Analyst Decision
- TCMD Buy
- PROK Buy
- Analyst Count
- TCMD 4
- PROK 5
- Target Price
- TCMD $16.83
- PROK $6.25
- AVG Volume (30 Days)
- TCMD 180.9K
- PROK 2.5M
- Earning Date
- TCMD 11-03-2025
- PROK 11-11-2025
- Dividend Yield
- TCMD N/A
- PROK N/A
- EPS Growth
- TCMD N/A
- PROK N/A
- EPS
- TCMD 0.63
- PROK N/A
- Revenue
- TCMD $298,851,000.00
- PROK $527,000.00
- Revenue This Year
- TCMD $8.78
- PROK $338.06
- Revenue Next Year
- TCMD $8.49
- PROK N/A
- P/E Ratio
- TCMD $23.87
- PROK N/A
- Revenue Growth
- TCMD 6.15
- PROK N/A
- 52 Week Low
- TCMD $8.61
- PROK $0.46
- 52 Week High
- TCMD $21.10
- PROK $7.13
- Technical
- Relative Strength Index (RSI)
- TCMD 65.46
- PROK 54.93
- Support Level
- TCMD $13.48
- PROK $2.34
- Resistance Level
- TCMD $15.48
- PROK $3.02
- Average True Range (ATR)
- TCMD 0.37
- PROK 0.17
- MACD
- TCMD 0.05
- PROK 0.03
- Stochastic Oscillator
- TCMD 66.83
- PROK 65.59
About TCMD Tactile Systems Technology Inc.
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.